Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,742,418
-$2,277,855 QoQ
Shares Held
167,732
-20.0% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Mar 31, 2026CallValue
$2,602,920
CallShares
159,200
PutValue
$2,656,875
PutShares
162,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. QURE ranks #56 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in QURE
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,602,920 | 159,200 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $2,656,875 | 162,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $2,742,418 | 167,732 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,020,273 | 209,790 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $6,879,875 | 287,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $3,888,625 | 162,500 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $11,107,811 | 190,300 | Put | Sole | 2026-03-31 | |
| 2025-09-30 | $5,440,084 | 93,200 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $6,745,353 | 115,562 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $2,256,886 | 161,900 | Call | Sole | 2026-02-27 | |
| 2025-06-30 | $1,394,000 | 100,000 | Put | Sole | 2026-02-27 | |
| 2025-06-30 | $1,240,855 | 89,014 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $270,300 | 25,500 | Call | Sole | 2026-03-17 | |
| 2025-03-31 | $718,085 | 67,744 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $127,911 | 7,243 | Shares | Sole | 2026-03-19 | |
| 2024-12-31 | $1,024,280 | 58,000 | Call | Sole | 2026-03-19 | |
| 2024-09-30 | $13,158 | 2,669 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $4,990 | 1,114 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $7,420 | 1,427 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $1,011,904 | 149,469 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $6,639,960 | 989,562 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $1,806,473 | 157,633 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,359,147 | 67,485 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,426,710 | 107,045 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $2,603,700 | 138,790 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $177,154 | 9,504 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $423,179 | 23,419 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $68,773 | 3,316 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $690,135 | 21,560 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $33,202 | 1,078 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $345,592 | 10,258 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $392,479 | 10,863 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $382,553 | 10,387 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $580,643 | 12,886 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||